THE ROLE OF NONCODING RNAS IN THE PROGRESSION OF IDH-MUTANT ASTROCYTOMAS TO GRADE 4

被引:0
|
作者
Hartewig, A. [1 ,2 ]
Jaatinen, S. [1 ,2 ]
Annala, M. [1 ,2 ]
Helen, P. [3 ,4 ]
Haapasalo, J. [5 ,6 ,7 ]
Zhang, W. [8 ]
Haapasalo, H. [3 ,4 ,7 ]
Nykter, M. [1 ,2 ]
Rautajoki, K. J. [1 ,2 ,9 ]
机构
[1] Tampere Univ, Fac Med & Hlth Technol, Prostate Canc Res Ctr, Tampere, Finland
[2] Tampere Univ Hosp, Tays Canc Ctr, Tampere, Finland
[3] Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland
[4] Tays Canc Ctr, Tampere, Finland
[5] Tampere Univ Hosp, Dept Neurosurg, Tampere, Finland
[6] Tampere Univ, Tampere, Finland
[7] Tampere Univ Hosp, Fimlab Labs Ltd, Tampere, Finland
[8] Wake Forest Baptist Comprehens Canc Ctr, Canc Genom & Precis Oncol, Winston Salem, NC USA
[9] Tampere Univ, Tampere Inst Adv Study, Tampere, Finland
关键词
D O I
10.1093/neuonc/noad137.213
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P10.15.A
引用
收藏
页数:1
相关论文
共 50 条
  • [21] GENETIC SUSCEPTIBILITY AND EVOLUTION OF PEDIATRIC IDH-MUTANT INFILTRATING ASTROCYTOMAS
    Bornhorst, Miriam
    Goecks, Jeremy
    Boue, Daniel R.
    Broniscer, Alberto
    Hwang, Eugene
    Koschmann, Carl
    Marks, Asher
    Mody, Rajen
    Mueller, Sabine
    Orr, Brent
    Packer, Roger
    Solomon, David A.
    Turner, Joyce
    Vortmeyer, Alexander
    Nazarian, Javad
    Ho, Cheng-Ying
    NEURO-ONCOLOGY, 2017, 19 : 195 - 195
  • [22] CDKN2A/B deletion in IDH-mutant astrocytomas
    Ranade, M.
    Sahay, A.
    Gupta, T.
    Moiyadi, A.
    Shetty, P.
    Shetty, O.
    Kannan, S.
    Sridhar, E.
    BRAIN PATHOLOGY, 2023, 33
  • [23] FH-mutant glioma displaying the epigenetic signature of IDH-mutant astrocytomas
    Zschernack, Valentina
    Thomas, Christian
    Schaub, Christina
    Kristiansen, Glen
    Waha, Andreas
    Goschzik, Tobias
    Herrlinger, Ulrich
    Pietsch, Torsten
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2024, 83 (10): : 887 - 889
  • [24] Homozygous deletion ofCDKN2Aby fluorescence in situ hybridization is prognostic in grade 4, but not grade 2 or 3, IDH-mutant astrocytomas
    Marker, Daniel F.
    Pearce, Thomas M.
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2020, 8 (01)
  • [25] CDKN2A deletion and radiation sensitivity in IDH-mutant astrocytomas
    Muzyka, Logan
    Kitagawa, Yosuke
    Nasser, Ali Mohamed
    Wetzel, Ethan A.
    Miller, Julie J.
    Wakimoto, Hiroaki
    Cahill, Daniel P.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [26] MRI-Based Radiomics Combined with Deep Learning for Distinguishing IDH-Mutant WHO Grade 4 Astrocytomas from IDH-Wild-Type Glioblastomas
    Hosseini, Seyyed Ali
    Hosseini, Elahe
    Hajianfar, Ghasem
    Shiri, Isaac
    Servaes, Stijn
    Rosa-Neto, Pedro
    Godoy, Laiz
    Nasrallah, MacLean P.
    O'Rourke, Donald M.
    Mohan, Suyash
    Chawla, Sanjeev
    CANCERS, 2023, 15 (03)
  • [27] CLINICAL AND RADIOGRAPHIC PREDICTORS OF PROGNOSIS IN ASTROCYTOMA, IDH-MUTANT, WHO GRADE 4
    Lasica, Aleksandra B.
    Lan, Zhou
    Miller, Julie J.
    Russ, Alyssa
    Westergaard, Catharina
    Lee, Eudocia Q.
    Chukwueke, Ugonma
    Castro, Luis Nicolas Gonzalez
    Figueroa, Jose Ricardo McFaline
    Aquilanti, Elisa
    Nayak, Lakshmi
    Beroukhim, Rameen
    Batchelor, Tracy
    Nakhate, Vihang
    Lanman, Tyler
    Botero, Juan Pablo Ospina
    Stec, Natalie
    Reardon, David A.
    Wen, Patrick Y.
    Youssef, Gilbert
    NEURO-ONCOLOGY, 2024, 26
  • [28] Global DNA methylation profiling reveals chromosomal instability in IDH-mutant astrocytomas
    Liu, Yan
    Sathe, Adwait Amod
    Abdullah, Kalil G.
    McBrayer, Samuel K.
    Adams, Steven H.
    Brenner, Andrew J.
    Hatanpaa, Kimmo J.
    Viapiano, Mariano S.
    Xing, Chao
    Walker, Jamie M.
    Richardson, Timothy E.
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2022, 10 (01)
  • [29] TUMOR LOCATION IS ASSOCIATED WITH CDKN2A STATUS IN IDH-MUTANT ASTROCYTOMAS
    Graber, Jerome
    Cimino, Patrick
    NEURO-ONCOLOGY, 2020, 22 : 5 - 5
  • [30] INFRATENTORIAL IDH-MUTANT ASTROCYTOMAS REQUIRE HIGH INDEX OF SUSPICION FOR ACCURATE DIAGNOSIS
    Ormond, David
    Guzman, Samuel
    Ney, Douglas
    DeMasters, B. K.
    NEURO-ONCOLOGY, 2023, 25